Dabigatran Etexilate Versus Warfarin in the Treatment of Venous Thromboembolism

被引：0

作者：

Schulman, Sam ^{[1
]}

Eriksson, Henry ^{[2
]}

Goldhaber, Samuel Z. ^{[3
]}

Kakkar, Ajay K. ^{[4
]}

Kearon, Clive ^{[5
]}

Mismetti, Patrick ^{[6
]}

Schellong, Sebastian M. ^{[7
]}

Baanstra, David ^{[8
]}

Schnee, Janet ^{[9
]}

机构：

[1] McMaster Univ, Dept Med, Hamilton, ON, Canada

[2] Sahlgrens Univ Hosp, Gothenburg, Sweden

[3] Brigham & Womens Hosp, Boston, MA 02115 USA

[4] Barts & London Queen Marys Sch Med & Dent, Thrombosis Res Inst, London, England

[5] McMaster Univ Clin, Henderson Hosp, Hamilton, ON, Canada

[6] Bellevue Hosp, St Etienne, France

[7] Municipal Hosp Friedrichstadt, Med Div 2, Dresden, Germany

[8] Boehringer Ingelheim GmbH & Co KG, Clin Res, Alkmaar, Netherlands

[9] Boehringer Ingelheim GmbH & Co KG, Ridgefield, CT USA

来源：

BLOOD | 2009年 / 114卷 / 22期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3 / 3

页数：1

共 50 条

[1] Dabigatran versus Warfarin for Venous Thromboembolism
Peetz, Dirk
Lackner, Karl J.
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (11): : 1050 - 1050
[2] DABIGATRAN ETEXILATE IN VENOUS THROMBOEMBOLISM
Ferrer, Elisa
DRUGS OF TODAY, 2009, 45 (10) : 715 - 724
[3] Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism.
Schulman, Sam
Kearon, Clive
Kakkar, Ajay K.
Mismetti, Patrick
Schellong, Sebastian
Eriksson, Henry
Baanstra, David
Schnee, Janet
Goldhaber, Samuel Z.
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (24): : 2342 - 2352
[4] Dabigatran etexilate and treatment of acute venous thromboembolism in children
Kenet, Gili
LANCET HAEMATOLOGY, 2021, 8 (01): : E2 - E3
[5] Dabigatran etexilate for prevention of venous thromboembolism
Eikelboom, John E.
Weitz, Jeffrey I.
THROMBOSIS AND HAEMOSTASIS, 2009, 101 (01) : 2 - 4
[6] Dabigatran etexilate for venous thromboembolism: a safety evaluation
Brown, Richard
Lip, Gregory Y. H.
Gallego, Pilar
EXPERT OPINION ON DRUG SAFETY, 2014, 13 (05) : 639 - 647
[7] Dabigatran Etexilate: A Review in Pediatric Venous Thromboembolism
Julia Paik
Pediatric Drugs, 2022, 24 : 423 - 431
[8] Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer
Schulman, Sam
Goldhaber, Samuel Z.
Kearon, Clive
Kakkar, Ajay K.
Schellong, Sebastian
Eriksson, Henry
Hantel, Stefan
Feuring, Martin
Kreuzer, Joerg
THROMBOSIS AND HAEMOSTASIS, 2015, 114 (01) : 150 - 157
[9] Dabigatran Etexilate: A Review in Pediatric Venous Thromboembolism
Paik, Julia
PEDIATRIC DRUGS, 2022, 24 (04) : 423 - 431
[10] Dabigatran Etexilate: A Review of Its Use in the Treatment of Acute Venous Thromboembolism and Prevention of Venous Thromboembolism Recurrence
Greig, Sarah L.
McKeage, Kate
DRUGS, 2014, 74 (15) : 1785 - 1800

← 1 2 3 4 5 →